表紙
市場調查報告書

帶狀皰疹疫苗的全球市場:2020年∼2024年

Global Shingles Vaccine Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 928339
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
帶狀皰疹疫苗的全球市場:2020年∼2024年 Global Shingles Vaccine Market 2020-2024
出版日期: 2020年03月10日內容資訊: 英文 120 Pages
簡介

全球帶狀皰疹疫苗市場在2020年∼2024年間,預測將以7%的年複合成長率推移,並成長到10億8,000萬美元。預計對市場有利的償付制度,及帶狀皰疹疫苗的認證,罹患率及高得病率等將促進這個市場成長。

本報告提供全球帶狀皰疹疫苗市場調查,提供市場概要,各類型·各地區的市場規模的變化與預測,市場成長要素及課題,競爭情形,主要企業的簡介等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模
  • 市場預測

波特的五力分析

市場區隔:各類型

  • 市場區隔:各類型
  • 市場比較:各類型
  • 重組疫苗
  • 減毒活病毒疫苗
  • 市場機會:各類型

客戶形勢

  • 概要

市場區隔:各地區

  • 市場區隔:各地區
  • 市場比較:各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區
  • 主要國家
  • 市場機會:各地區

成長要素·課題·趨勢

  • 市場成長要素
  • 交易量的成長要素 - 需求主導的成長
  • 交易量的成長要素 - 供給主導的成長
  • 交易量的成長要素 - 外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格成長要素 - 通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • CanSino Biologics, Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • SK Bioscience
  • Vaccitech Ltd.

附錄

目錄
Product Code: IRTNTR41592

Technavio has been monitoring the global shingles vaccine market 2020-2024 and it is poised to grow by USD 1.08 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global shingles vaccine market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by approval of shingles vaccines and favorable reimbursement policies. In addition, high incidence and prevalence of shingles is anticipated to boost the growth of the global shingles vaccine market 2020-2024 as well.

Market Segmentation

Technavio's ‘global shingles vaccine market 2020-2024’ is segmented as below:

Type:

  • Recombinant Vaccines
  • Live-attenuated Vaccines

Geographic segmentation

  • North America
  • Europe
  • Asia
  • ROW

Key Trends for global shingles vaccine market 2020-2024 growth

This study identifies high incidence and prevalence of shingles as the prime reasons driving the global shingles vaccine market 2020-2024 growth during the next few years.

Prominent vendors in global shingles vaccine market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global shingles vaccine market 2020-2024, including some of the vendors such as CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience and Vaccitech Ltd. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type placement
  • Recombinant vaccines - Market size and forecast 2019-2024
  • Live-attenuated vaccines - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • CanSino Biologics, Inc.
  • Curevo Inc.
  • GeneOne Life Science Inc.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • SK Bioscience
  • Vaccitech Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Type placement - Market share 2019-2024 (%)
  • 23.Comparison by Type placement
  • 24.Recombinant vaccines - Market size and forecast 2019-2024 ($ million)
  • 25.Recombinant vaccines - Year-over-year growth 2019-2024 (%)
  • 26.Live-attenuated vaccines - Market size and forecast 2019-2024 ($ million)
  • 27.Live-attenuated vaccines - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by Type
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.Asia - Market size and forecast 2019-2024 ($ million)
  • 37.Asia - Year-over-year growth 2019-2024 (%)
  • 38.ROW - Market size and forecast 2019-2024 ($ million)
  • 39.ROW - Year-over-year growth 2019-2024 (%)
  • 40.Key leading countries
  • 41.Market opportunity by geography ($ million)
  • 42.Impact of drivers and challenges
  • 43.Vendor landscape
  • 44.Landscape disruption
  • 45.Industry risks
  • 46.Vendors covered
  • 47.Market positioning of vendors
  • 48.CanSino Biologics Inc. - Overview
  • 49.CanSino Biologics Inc. - Product and service
  • 50.CanSino Biologics Inc. - Key offerings
  • 51.CanSino Biologics Inc. - Key customers
  • 52.CanSino Biologics Inc. - Segment focus
  • 53.Curevo Inc. - Overview
  • 54.Curevo Inc. - Product and service
  • 55.Curevo Inc. - Key offerings
  • 56.Curevo Inc. - Key customers
  • 57.Curevo Inc. - Segment focus
  • 58.GeneOne Life Science Inc. - Overview
  • 59.GeneOne Life Science Inc. - Product and service
  • 60.GeneOne Life Science Inc. - Key offerings
  • 61.GeneOne Life Science Inc. - Key customers
  • 62.GeneOne Life Science Inc. - Segment focus
  • 63.GlaxoSmithKline Plc - Overview
  • 64.GlaxoSmithKline Plc - Business segments
  • 65.GlaxoSmithKline Plc - Key offerings
  • 66.GlaxoSmithKline Plc - Key customers
  • 67.GlaxoSmithKline Plc - Segment focus
  • 68.Merck & Co. Inc. - Overview
  • 69.Merck & Co. Inc. - Business segments
  • 70.Merck & Co. Inc. - Key offerings
  • 71.Merck & Co. Inc. - Key customers
  • 72.Merck & Co. Inc. - Segment focus
  • 73.SK Bioscience - Overview
  • 74.SK Bioscience - Product and service
  • 75.SK Bioscience - Key offerings
  • 76.SK Bioscience - Key customers
  • 77.SK Bioscience - Segment focus
  • 78.Vaccitech Ltd. - Overview
  • 79.Vaccitech Ltd. - Product and service
  • 80.Vaccitech Ltd. - Key offerings
  • 81.Vaccitech Ltd. - Key customers
  • 82.Vaccitech Ltd. - Segment focus
  • 83.Currency conversion rates for US$
  • 84.Research Methodology
  • 85.Validation techniques employed for market sizing
  • 86.Information sources
  • 87.List of abbreviations